Abstract

Resveratrol (Rsv) has been shown to extend the lifespan of diverse range of species to activate sirtuin (SIRT) family proteins, which belong to the class III NAD+ dependent histone de-acetylases (HDACs).The protein deacetylating enzyme SIRT1 has been implicated in the regulation of cellular senescence and aging processes in mammalian cells. However, higher concentrations of this natural compound cause cell death. Therefore, novel compounds that have reduced cellular toxicity will be required for anti-aging therapy, especially for dermatological treatments. In this study, the Luciferase (Luc) expression vector pGL4-SIRT1 containing 396-bp of the 5’-upstream region of the human SIRT1 gene was transfected into HeLa S3 cells and Luc assay was performed. The results showed that treatments with the natural compound, α-, β- and γ-thujaplicins increase the SIRT1 promoter activity more than that with Rsv. Moreover, we carried out multiple transfection of Luc reporter vectors containing 5’-upstream regions of various human telomere maintenance factor encoding genes, and observed that β−thujaplicin (hinokitiol) activates TERT, RTEL, TRF1, DKC1, RAP1 (TERF2IP) and TPP1(ACD) promoters. These results suggest that that the β−thujaplicin could be used as anti-aging drugs to delay cellular senescence through activating SIRT1 transcription along with strengthening stability of telomeres.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.